Experienced in Minimal Change Disease

Philipp Enghard

Berlin, BE, DE 
Experienced in Minimal Change Disease
Berlin, BE, DE 
OverviewLocationsClinical Research

Overview

Philipp Enghard practices in Berlin, Germany. Mr. Enghard is rated as an Experienced expert by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Lupus Nephritis, Glomerulonephritis, Systemic Lupus Erythematosus (SLE), Respiratory Acidosis, and Kidney Transplant.

His clinical research consists of co-authoring 73 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Minimal Change Disease.

Gender
Male

Locations

Berlin, BE, Germany
Other Locations
Luebeck, SH, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Urinary T Lymphocytes Predict Renal Flares in Patients With Inactive Anti-neutrophil Cytoplasmic Antibody (ANCA) Associated Glomerulonephritis
Urinary T Lymphocytes Predict Renal Flares in Patients With Inactive Anti-neutrophil Cytoplasmic Antibody (ANCA) Associated Glomerulonephritis
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Diagnostic test
Phenotype of Urinary CD4+ T Cells as Biomarkers for Prediction of Outcome in ANCA Glomerulonephritis
Phenotype of Urinary CD4+ T Cells as Biomarkers for Prediction of Outcome in ANCA Glomerulonephritis
Enrollment Status: Unknown
Publish Date: July 29, 2022
Intervention Type: Diagnostic test
Prediction of Lupus Renal Flares Study
Prediction of Lupus Renal Flares Study
Enrollment Status: Unknown
Publish Date: May 10, 2022
Phenotype of Urinary CD4+ T Cells as Biomarkers for Prediction of Outcome in Lupus Nephritis
Phenotype of Urinary CD4+ T Cells as Biomarkers for Prediction of Outcome in Lupus Nephritis
Enrollment Status: Unknown
Publish Date: March 09, 2022
Intervention Type: Diagnostic test
View 3 Less Clinical Trials

72 Total Publications

Multicentre pragmatic embedded stepped wedge cluster randomised trial comparing glucose 5% with sodium chloride 0.9% as the default drug diluent in the ICU: the sweet-water trial protocol.
Multicentre pragmatic embedded stepped wedge cluster randomised trial comparing glucose 5% with sodium chloride 0.9% as the default drug diluent in the ICU: the sweet-water trial protocol.
Journal: BMJ open
Published: June 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Enghard's expertise for a condition
ConditionClose
    View All 12 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile